SG Americas Securities LLC Increases Position in Centene Corporation $CNC

SG Americas Securities LLC grew its position in Centene Corporation (NYSE:CNC) by 375.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 802,206 shares of the company’s stock after purchasing an additional 633,335 shares during the quarter. SG Americas Securities LLC owned approximately 0.16% of Centene worth $33,011,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Addison Advisors LLC increased its holdings in Centene by 455.6% in the third quarter. Addison Advisors LLC now owns 739 shares of the company’s stock valued at $26,000 after buying an additional 606 shares during the last quarter. Mowery & Schoenfeld Wealth Management LLC purchased a new stake in Centene during the 3rd quarter worth about $27,000. GoalVest Advisory LLC acquired a new position in shares of Centene during the 4th quarter worth about $37,000. Union Bancaire Privee UBP SA purchased a new position in shares of Centene in the 4th quarter valued at about $37,000. Finally, WPG Advisers LLC raised its position in shares of Centene by 44.5% during the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company’s stock worth $33,000 after acquiring an additional 282 shares in the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on CNC shares. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $41.00 price target on shares of Centene in a report on Monday, February 9th. Wall Street Zen downgraded shares of Centene from a “buy” rating to a “hold” rating in a research report on Sunday, February 15th. Argus upgraded shares of Centene to a “hold” rating in a report on Monday, February 9th. Sanford C. Bernstein reiterated an “outperform” rating and set a $59.00 price target on shares of Centene in a research note on Tuesday, January 6th. Finally, Robert W. Baird upped their price objective on shares of Centene from $28.00 to $36.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Three research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $41.81.

Centene Stock Performance

Shares of CNC opened at $32.61 on Thursday. The company’s 50 day simple moving average is $40.94 and its 200-day simple moving average is $38.69. The firm has a market cap of $16.03 billion, a PE ratio of -2.39, a price-to-earnings-growth ratio of 0.73 and a beta of 0.48. Centene Corporation has a 12-month low of $25.08 and a 12-month high of $66.03. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.87.

Centene (NYSE:CNC) last released its quarterly earnings results on Friday, February 6th. The company reported ($1.19) EPS for the quarter, beating the consensus estimate of ($1.22) by $0.03. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. The firm had revenue of $49.73 billion during the quarter, compared to the consensus estimate of $48.41 billion. During the same quarter in the prior year, the firm earned $0.80 EPS. Centene’s revenue for the quarter was up 21.9% on a year-over-year basis. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. As a group, equities analysts predict that Centene Corporation will post 6.86 EPS for the current year.

About Centene

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.